The Patented Medicine Prices Review Board (French: Conseil d'examen du prix des médicaments brevetés) is a federal quasi-judicial regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of patented medication charged by manufacturers of patented drugs are not excessive. The board does this through its role as a regulator, and through its reporting on trends, research and development in the Canadian pharmaceutical industry.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
foaf:homepage | |
name |
|
foaf:depiction | |
location | |
dcterms:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage |
|
Link from a Wikipage to an external page |
|
sameAs | |
dbp:wikiPageUsesTemplate | |
thumbnail | |
budget |
|
employees |
|
headquarters | |
jurisdiction | |
logo |
|
native name |
|
website | |
has abstract |
|
chief1 name |
|
chief1 position |
|
chief2 name |
|
chief2 position |
|
chief3 name |
|
chief3 position |
|
keydocument |
|
minister1 name | |
minister1 pfo | |
gold:hypernym | |
schema:sameAs | |
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
jurisdiction | |
budget ($) |
|
formation year |
|
number of employees | |
headquarter | |
leader | |
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of |